Back to mobile site

More on RYTM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+11.0% Growth)
- Ratings (9.0 Score)
- Holders
- FDA

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Rhythm Pharmaceuticals (NQ:RYTM)
Delayed: 99.68 +1.67 (1.70%)
Prev. Close $98.01  
Open$101.17 
52 Wk High$ 
52 Wk Low$ 
Day High$102.00 
Day Low$99.48 
P/E N/A  
EPS$ 
Volume282,814 

Friends, Peers and Foes (?): ABVX, CYTK, RAPP, OCUL, VRTX (more...)

Sep 14, 2026 07:37 PM Form 4 RHYTHM PHARMACEUTICALS, For: Sep 14 Filed by: Meeker David P
Sep 14, 2026 04:50 PM Form 144 RHYTHM PHARMACEUTICALS, Filed by: Meeker David P
Sep 14, 2026 06:11 AM Leerink Assumes Rhythm Pharmaceuticals (RYTM) at Outperform
Sep 14, 2026 06:06 AM KeyBanc Starts Rhythm Pharmaceuticals (RYTM) at Overweight
Sep 10, 2026 08:00 AM Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
Aug 27, 2026 04:35 PM Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold
Aug 24, 2026 08:03 AM Rhythm gets Japan approval for obesity drug Imcivree
Aug 24, 2026 08:00 AM Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
Aug 18, 2026 05:36 PM Form 4 RHYTHM PHARMACEUTICALS, For: Aug 17 Filed by: Joshi Manher
Aug 18, 2026 05:17 PM Form 3 RHYTHM PHARMACEUTICALS, For: Aug 17 Filed by: Joshi Manher
View All Articles

Entities mentioned with RYTM

View All Entities